Verrica Pharmaceuticals Inc. (VRCA) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts VRCA Hot Sheet
Join SI Premium – FREE
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q3 EPS of ($0.43), $0.05 worse than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PayPal's CEO Is Planning to Go It Alone and Fix the Payments Giant - WSJ
- ZoomInfo MCP Server listed on Cursor Marketplace
- Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
